167 related articles for article (PubMed ID: 19558657)
1. The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta.
Takayama M; Yao K; Wada M
J Biomed Sci; 2009 Jun; 16(1):57. PubMed ID: 19558657
[TBL] [Abstract][Full Text] [Related]
2. Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells.
Matsubara M; Hasegawa K
Atherosclerosis; 2005 Jan; 178(1):57-66. PubMed ID: 15585201
[TBL] [Abstract][Full Text] [Related]
3. Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release.
Matsubara M; Yao K; Hasegawa K
Pharmacol Res; 2006 Jan; 53(1):35-43. PubMed ID: 16172001
[TBL] [Abstract][Full Text] [Related]
4. Effects of benidipine, a dihydropyridine-Ca2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells.
Matsubara M; Hasegawa K
Eur J Pharmacol; 2004 Sep; 498(1-3):303-14. PubMed ID: 15364009
[TBL] [Abstract][Full Text] [Related]
5. Benidipine, a dihydropyridine-Ca2+ channel blocker, increases the endothelial differentiation of endothelial progenitor cells in vitro.
Ando H; Nakanishi K; Shibata M; Hasegawa K; Yao K; Miyaji H
Hypertens Res; 2006 Dec; 29(12):1047-54. PubMed ID: 17378377
[TBL] [Abstract][Full Text] [Related]
6. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
7. Perturbation by lysophosphatidylcholine of membrane permeability in cultured vascular smooth muscle and endothelial cells.
Leung YM; Xion Y; Ou YJ; Kwan CY
Life Sci; 1998; 63(11):965-73. PubMed ID: 9747897
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
Yokoyama K; Ishibashi T; Ohkawara H; Kimura J; Matsuoka I; Sakamoto T; Nagata K; Sugimoto K; Sakurada S; Maruyama Y
Circulation; 2002 Feb; 105(8):962-7. PubMed ID: 11864926
[TBL] [Abstract][Full Text] [Related]
9. Effects of lysophosphatidylcholine on bovine aortic endothelial cells in culture.
Su Z; Ling Q; Guo ZG
Cardioscience; 1995 Mar; 6(1):31-7. PubMed ID: 7605894
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine inhibits receptor-mediated Ca2+ mobilization in intact endothelial cells of rabbit aorta.
Miwa Y; Hirata K; Kawashima S; Akita H; Yokoyama M
Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1561-7. PubMed ID: 9301636
[TBL] [Abstract][Full Text] [Related]
11. Spotted fever rickettsia-induced microvascular endothelial barrier dysfunction is delayed by the calcium channel blocker benidipine.
Kim Y; Clemens EG; Farner JM; Londono-Barbaran A; Grab DJ; Dumler JS
Biochem Biophys Res Commun; 2023 Jun; 663():96-103. PubMed ID: 37121130
[TBL] [Abstract][Full Text] [Related]
12. Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta.
Deng HF; Xiong Y
Acta Pharmacol Sin; 2005 Jan; 26(1):92-8. PubMed ID: 15659120
[TBL] [Abstract][Full Text] [Related]
13. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
14. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats.
Dohi Y; Kojima M; Sato K
Hypertension; 1996 Jul; 28(1):58-63. PubMed ID: 8675265
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells.
Inoue N; Hirata K; Yamada M; Hamamori Y; Matsuda Y; Akita H; Yokoyama M
Circ Res; 1992 Dec; 71(6):1410-21. PubMed ID: 1330355
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
[TBL] [Abstract][Full Text] [Related]
17. Effect of benidipine on depolarizing stimulation-induced increase of intracellular calcium concentration in cultured mouse hippocampal neurons.
Tsukuda E; Matsuda Y
Jpn J Pharmacol; 1999 Dec; 81(4):401-3. PubMed ID: 10669048
[TBL] [Abstract][Full Text] [Related]
18. Effects of benidipine and candesartan on kidney and vascular function in hypertensive Dahl rats.
Yao K; Sato H; Sonoda R; Ina Y; Suzuki K; Ohno T
Hypertens Res; 2003 Jul; 26(7):569-76. PubMed ID: 12924625
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine alters vascular tone in rat aorta by suppressing endothelial [Ca(2+)](I) signaling.
Huang TY; Chen HI; Liu CY; Jen CJ
J Biomed Sci; 2002; 9(4):327-33. PubMed ID: 12145530
[TBL] [Abstract][Full Text] [Related]
20. Electron paramagnetic resonance investigation on modulatory effect of benidipine on membrane fluidity of erythrocytes in essential hypertension.
Tsuda K
Heart Vessels; 2008 Mar; 23(2):134-9. PubMed ID: 18389339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
